tiprankstipranks
Fresh2 Group (FRES)
NASDAQ:FRES
Holding FRES?
Track your performance easily

Fresh2 Group (FRES) Stock Price & Analysis

95 Followers

FRES Stock Chart & Stats


Financials

Annual

Ownership Overview

0.01%99.99%
Insiders
― Other Institutional Investors
99.99% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

FRES FAQ

What was Fresh2 Group’s price range in the past 12 months?
Fresh2 Group lowest stock price was $0.85 and its highest was $12.75 in the past 12 months.
    What is Fresh2 Group’s market cap?
    Currently, no data Available
    When is Fresh2 Group’s upcoming earnings report date?
    Fresh2 Group’s upcoming earnings report date is May 20, 2025 which is in 178 days.
      How were Fresh2 Group’s earnings last quarter?
      Currently, no data Available
      Is Fresh2 Group overvalued?
      According to Wall Street analysts Fresh2 Group’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Fresh2 Group pay dividends?
        Fresh2 Group does not currently pay dividends.
        What is Fresh2 Group’s EPS estimate?
        Fresh2 Group’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Fresh2 Group have?
        Fresh2 Group has 2,375,840 shares outstanding.
          What happened to Fresh2 Group’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Fresh2 Group?
          Currently, no hedge funds are holding shares in FRES
          ---

          Fresh2 Group Stock Smart Score

          Company Description

          Fresh2 Group

          Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China.
          ---
          Similar Stocks
          Company
          Price & Change
          Follow
          Canopy Growth
          Oragenics
          Atara Biotherapeutics
          Rocket Pharmaceuticals
          Popular Stocks
          ---
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis